LRRC19—A Bridge between Selenium Adjuvant Therapy and Renal Clear Cell Carcinoma: A Study Based on Datamining

Kidney renal clear cell carcinoma (KIRC) is the most common and fatal subtype of renal cancer. Antagonistic associations between selenium and cancer have been reported in previous studies. Selenium compounds, as anti-cancer agents, have been reported and approved for clinical trials. The main active...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yitong, Wang, Jiaxing, Liu, Xiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230350/
https://www.ncbi.nlm.nih.gov/pubmed/32316597
http://dx.doi.org/10.3390/genes11040440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230350/
https://www.ncbi.nlm.nih.gov/pubmed/32316597
http://dx.doi.org/10.3390/genes11040440

Ejemplares similares